相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: A single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial
C. Ashley Finlen Copeland et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients
J. M. Iwasenko et al.
TRANSPLANT INFECTIOUS DISEASE (2011)
Universal Prophylaxis is Cost Effective in Cytomegalovirus Serology-Positive Kidney Transplant Patients
Fu L. Luan et al.
TRANSPLANTATION (2011)
Cytomegalovirus Pneumonitis Is a Risk for Bronchiolitis Obliterans Syndrome in Lung Transplantation
Laurie D. Snyder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation
Scott M. Palmer et al.
ANNALS OF INTERNAL MEDICINE (2010)
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis
Dimitra Mitsani et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Valganciclovir prophylaxis for cytomegalovirus infection in thoracic transplant patients: retrospective study of efficacy, safety, and drug exposure
S. Lefeuvre et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
An International Survey of Cytomegalovirus Management Practices in Lung Transplantation
Dalyce M. Zuk et al.
TRANSPLANTATION (2010)
International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2010)
Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States
Emily A. Blumberg et al.
TRANSPLANTATION (2010)
Preemptive Therapy for Systemic and Pulmonary Human Cytomegalovirus Infection in Lung Transplant Recipients
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Interlaboratory Comparison of Cytomegalovirus Viral Load Assays
X. L. Pang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
A Multicenter Study of Valganciclovir Prophylaxis up to Day 120 in CMV-Seropositive Lung Transplant Recipients
V. Monforte et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
A Commutable Cytomegalovirus Calibrator Is Required to Improve the Agreement of Viral Load Values between Laboratories
Angela M. Caliendo et al.
CLINICAL CHEMISTRY (2009)
Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients
Laurent Chiche et al.
CRITICAL CARE MEDICINE (2009)
Cytomegalovirus Prevention in High-risk Lung Transplant Recipients: Comparison of 3-vs 12-Month Valganciclovir Therapy
Peter Jaksch et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy
Andre C. Kalil et al.
PLOS ONE (2009)
Lack of Association Between β-herpesvirus Infection and Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients in the Era of Antiviral Prophylaxis
Oriol Manuel et al.
TRANSPLANTATION (2009)
Cytomegalovirus DNA Load Patterns Developing After Lung Transplantation Are Significantly Correlated With Long-Term Patient Survival
Heidrun Kerschner et al.
TRANSPLANTATION (2009)
Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients
Gilberto Torres-Madriz et al.
CLINICAL INFECTIOUS DISEASES (2008)
Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation
Corinne Chmiel et al.
CLINICAL INFECTIOUS DISEASES (2008)
Cytomegalovirus reactivation in critically ill immunocompetent patients
Ajit P. Limaye et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Monitoring human cytomegalovirus infection in transplant recipients
Fausto Baldanti et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes
Albert J. Eid et al.
CLINICAL TRANSPLANTATION (2008)
Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients
W. Lawrence Drew
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
Clinical utility of CMV early and late transcript detection with NASBA in bronchoalveolar lavages
Maria Cristina Keightley et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients
RF Chemaly et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
C Paya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir
SM Palmer et al.
CLINICAL TRANSPLANTATION (2004)
Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: A longitudinal study of lung transplant recipients
GP Westall et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Cytomegalovirus and lung transplantation
MR Zamora
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation
MR Zamora et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
H Rollag et al.
CLINICAL MICROBIOLOGY AND INFECTION (2002)
Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays
AM Caliendo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients
SM Bhorade et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2001)
Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients
JL Sanchez et al.
TRANSPLANTATION (2001)
Quantification of cytomegalovirus DNA in BAL fluid -: A longitudinal study in lung transplant recipients
GC Riise et al.
CHEST (2000)
A prospective study of a quantitative PCR ELISA assay for the diagnosis of CMV pneumonia in lung and heart-transplant recipients
L Barber et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2000)
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
VC Emery et al.
LANCET (2000)
分享论文
